EPA:BOI - Euronext Paris - Matif - FR0000061129 - Common Stock - Currency: EUR
EPA:BOI (3/7/2025, 7:00:00 PM)
24
-0.7 (-2.83%)
The current stock price of BOI.PA is 24 EUR. In the past month the price decreased by -6.8%. In the past year, price decreased by -32.13%.
Symbol | Name | TA | FA | PE | Market Cap |
---|---|---|---|---|---|
1LLY.MI | ELI LILLY & CO | 67 | 760.43B | ||
LLY.DE | ELI LILLY & CO | 66.98 | 760.15B | ||
ZEG.DE | ASTRAZENECA PLC | 21.82 | 446.45B | ||
JNJ.DE | JOHNSON & JOHNSON | 16.81 | 372.31B | ||
1JNJ.MI | JOHNSON & JOHNSON | 16.61 | 367.98B | ||
NOV.DE | NOVO NORDISK A/S-B | 26.21 | 355.97B | ||
SNW.DE | SANOFI | 14.32 | 275.64B | ||
SAN.PA | SANOFI | 14.27 | 274.84B | ||
1SAN.MI | SANOFI | 14.19 | 273.18B | ||
6MK.DE | MERCK & CO. INC. | 12.64 | 224.82B | ||
1MRKX.MI | MERCK & CO. INC. | 12.47 | 221.79B | ||
1PFE.MI | PFIZER INC | 8.6 | 139.42B |
Boiron SA engages in the manufacturing and selling homeopathic medicines. The company is headquartered in Rontalon, Auvergne-Rhone-Alpes and currently employs 2,788 full-time employees. The firm develops, manufactures and markets single homeopathic medicines and drugs which are in the form of tablets, syrups, single-dose liquids and ointments. The company also produces medicines based on trace elements, phytotherapy remedies, food supplements, as well as health and beauty care products. In addition, the Company owns a research center, which works for the development of homeopathy within the world of medicine. Boiron SA operates through a number of subsidiaries, which are based in Italy, Spain, Belgium, the Czech Republic, Slovakia, Russia, Romania, Poland, Hungary, the United States, Canada and Brazil, among others.
BOIRON SA
2 avenue de l ouest Lyonnais
Rontalon AUVERGNE-RHONE-ALPES FR
Employees: 2788
Company Website: https://www.boiron.fr/
Investor Relations: https://www.boironfinance.fr/en/financial-information/annual-reports
Phone: 33478456100
The current stock price of BOI.PA is 24 EUR. The price decreased by -2.83% in the last trading session.
The exchange symbol of BOIRON SA is BOI and it is listed on the Euronext Paris - Matif exchange.
BOI.PA stock is listed on the Euronext Paris - Matif exchange.
BOIRON SA (BOI.PA) has a market capitalization of 421.20M EUR. This makes BOI.PA a Small Cap stock.
BOIRON SA (BOI.PA) currently has 2788 employees.
BOIRON SA (BOI.PA) has a resistance level at 25.59. Check the full technical report for a detailed analysis of BOI.PA support and resistance levels.
The Revenue of BOIRON SA (BOI.PA) is expected to decline by -2.5% in the next year. Check the estimates tab for more information on the BOI.PA EPS, Sales, EBIT and EBITDA future analyst estimates.
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
BOIRON SA (BOI.PA) has a dividend yield of 5.47%. The yearly dividend amount is currently 11.46. Check the full fundamental report for a detailed analysis of BOI.PA dividend history, reliability and sustainability.
BOIRON SA (BOI.PA) will report earnings on 2025-03-12, after the market close.
The PE ratio for BOIRON SA (BOI.PA) is 17.65. This is based on the reported non-GAAP earnings per share of 1.36 and the current share price of 24 EUR. Check the full fundamental report for a full analysis of the valuation metrics for BOI.PA.
ChartMill assigns a fundamental rating of 5 / 10 to BOI.PA. BOI.PA has an excellent financial health rating, but there are some minor concerns on its profitability.
Over the last trailing twelve months BOI.PA reported a non-GAAP Earnings per Share(EPS) of 1.36. The EPS decreased by -50.22% compared to the year before.
Industry Rank | Sector Rank | ||
---|---|---|---|
PM (TTM) | 4.92% | ||
ROA | 4.25% | ||
ROE | 6.35% | ||
Debt/Equity | 0.02 |
ChartMill assigns a Buy % Consensus number of 80% to BOI.PA. The Buy consensus is the average rating of analysts ratings from 5 analysts.
For the next year, analysts expect an EPS growth of -13.55% and a revenue growth -2.5% for BOI.PA